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Abstract
Background: Combat-related posttraumatic stress disorder (PTSD) can be a difficult condition to treat and has been
associated with serious medical and economic issues among U.S. military veterans. Distinguishing between treatment
responders vs. non-responders in this population has become an important public health priority. This study was conducted
to identify pre-treatment characteristics of U.S. veterans with combat-related PTSD that might contribute to favorable and
unfavorable responses to high value treatments for this condition.
Method: This study focused on 805 patients who completed a VHA PTSD residential program between 2000 and 2007.
These patients completed the PTSD Clinical Checklist at pre-treatment, post-treatment, and a four-month follow-up
assessment. Latent growth curve analysis (LCGA) was incorporated to determine trajectories of changes in PTSD across
these assessments and whether several key clinical concerns for this population were associated with their treatment
responses.
Study Findings: LCGA indicated three distinct trajectories in PTSD outcomes and identified several clinical factors that were
prospectively linked with changes in veterans’ posttraumatic symptomatology. When compared to a group with high PTSD
symptom severity that decreased over the program but relapsed at follow-up (41%), the near half (48.8%) of the sample
with an improving trajectory had less combat exposure and superior physical/mental health. However, when compared to a
minority (10.2%) with relatively low symptomatology that also remained somewhat stable, patients in the improving group
were younger and also reported greater combat exposure, poorer physical/mental health status, and more problems with
substance abuse before the start of treatment.
Conclusions: Findings suggest that veterans are most likely to benefit from residential treatment in an intermediate range
of symptoms and risk factors, including PTSD symptom severity, history of combat exposure, and comorbid issues with
physical/mental health. Addressing these factors in an integrative manner could help to optimize the effectiveness of
treatments of combat-related PTSD in many cases.
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Introduction
Treating combat-related posttraumatic stress disorder (PTSD)
effectively is a public health priority. The costs of PTSD to society
can be quite serious compared to other possible psychiatric
conditions that may emerge following war-zone service [1–3].
Although most military veterans do not suffer from long-term
consequences after deployment, an estimated 18.7% to 30% of
Vietnam Veterans met criteria for PTSD at some point after
returning to civilian life [4,5]. Research with Iraq/Afghanistan
Veterans has similarly documented PTSD prevalence rates of
approximately 12% to 20% among those who served in combat
operational capacities (e.g., infantry) [6,7]. The number of new
PTSD cases in the Veterans Health Administration (VHA) has
accordingly more than doubled since the start of these new wars
[8] and compensation for this condition has increased dramatically
during this period among U.S. veterans as well [9]. In a recent
evaluation of mental health services in the VHA, Watkins and
colleagues [10] also found that the average cost of a veteran with a
psychiatric disorder was 2.7 times higher than non-psychiatric
cases ($12,337/year) and that PTSD was the condition most
commonly associated with service utilization (comprising 43% of
psychiatric cases in the VHA).
Meta-analytic reviews have unfortunately documented that
psychological treatments for PTSD are less effective for improving
symptomatology among U.S. veterans than other trauma popu-
lations [11,12]. The Institute of Medicine (IOM) [13] has also
raised questions about treating at risk subpopulations of veterans
and concluded that ‘‘research on treatment of PTSD in U.S.
veterans is inadequate to answer questions about interventions,
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settings, and lengths of treatment that are applicable in this specific
population.’’ Although the VHA has taken steps to enhance the
quality of available psychological treatments for PTSD since
IOM’s review [14–16], a recent meta-analytic review of 24
outcome studies for combat-related PTSD [17] documented that
these treatments often generated smaller reductions in symptom-
atology than is customarily expected with professional therapeutic
interventions (overall d= .49). Goodson and colleagues also
documented that residential treatments in particular generated
small reductions in PTSD symptomatology (overall d= .19), which
aligns with earlier results for several smaller studies of individual
programs as well [18–21]. This outcome literature therefore
suggests that while there are promising psychotherapies for
combat-related PTSD, the subpopulation of veterans who have
the strongest need for effective mental health care are also the
most improbable of benefitting from services.
A number of factors may contribute to variability in veterans’
responses to psychological treatments for PTSD. When consider-
ing the challenges in residential treatments in particular, these
programs target severe cases of PTSD in which outpatient options
have typically been exhausted. With the wars in Iraq/Afghanistan,
residential programs are increasingly treating younger veterans
with acute forms of symptomatology [22]. However, when
compared to older counterparts from Vietnam and other eras,
these veterans may not have experienced the erosion of adaptive
resources that often accompanies a longer-term course of PTSD
[23]. War-zone service can also entail varying rates of exposure to
potential traumas that may differentially increase the risk for
PTSD [24] and engender possible moral/ethical challenges
related to combat-related decisions/actions [25]. Veterans can
also incur physical injuries in the war-zone and/or PTSD
symptomatology might reduce physical health status and increase
the risk for a variety of medical problems [26,27]. Of the 25%
percent of Iraq/Afghanistan veterans who received a psychiatric
diagnosis in the VHA prior to 2005, Seal and colleagues [28] also
found that 56% suffered from multiple mental health conditions
that may demand clinical attention. Other research has also
documented high rates of substance-related problems with
combat-exposed samples [29,30], which represents another
significant concern for this population.
These issues with physical and/or psychiatric comorbidity may
complicate treatment in many cases of combat-related PTSD [31–
33]. Studies have documented that clinicians frequently perceive
patients with PTSD and co-occurring substance use disorders
(SUDs) as being more difficult to treat than either disorder alone
[32,33]. For example, clinicians might struggle with anger and
frustration at patients’ self-destructive behaviors and lack of
insight/judgment into their substance misuse. Notwithstanding
recent innovations in psychotherapies for combat-related PTSD
[14–16], clinicians might also struggle to know how to best
prioritize and implement specific evidence-based interventions for
PTSD and SUD symptomatology (e.g., beginning exposure prior
to sustained period of sobriety). In cases of medical comorbidities,
clinicians might similarly struggle to collaborate with other health
care professionals outside of their training background and
balance the demands of psychological and medical treatments
that veterans might require. For example, although research is still
limited as to the consequences of physical health status on
outcomes of PTSD treatment, veterans’ posttraumatic symptom-
atology might hinder their ability to attend their appointments and
adhere to recommendations of medical providers. Similarly,
uncontrolled medical problems may conceivably exacerbate
posttraumatic symptomatology and limit veterans’ energy and
motivation to adequately engage in their mental health treatments.
Study Aims
The VHA will continue to assume primary responsibility for
addressing the many forms of PTSD in U.S. veterans. However, in
light of increasing demands for services since the U.S. involvement
in Iraq/Afghanistan, it is essential to better optimize PTSD
residential programs and other high value treatments for combat-
related PTSD. Focusing on clinical information from a PTSD
residential program over an eight-year period, the overarching
purpose of this study was to identify pre-treatment characteristics
that are associated with favorable responses to treatment. Namely,
we utilized latent class growth analysis (LCGA) to determine
trajectories of changes in PTSD symptomatology from baseline
through a four-month follow-up assessment. LCGA allows for the
empirical examination of the underlying heterogeneity within the
data, which is often simply modeled as error in other statistical
procedures. Specifically, LCGA tests whether the population
under study is composed of a mixture of distinct distributions or
‘‘classes’’ of individuals with differing trajectories of change over
time. LCGA also permits modeling of covariates as predictors of
class membership. Drawing on LCGA in this study, we anticipated
finding variability in veterans’ trajectories of PTSD. Namely, when
considering past research [11,12,17–21], we anticipated finding
that many of the patients would obtain significant benefit from
treatment along with a substantive minority who would not display
improvements in PTSD. We also hypothesized that responders
would be distinguished from these non-responders by several key
clinical concerns for this population – severity of baseline PTSD
symptomatology, chronicity of PTSD (i.e., older in age), greater
combat exposure, poorer physical health and mental health status,
and more problems with substance abuse.
Method
Setting and Participants
The present study utilized clinical information for 805 veterans
who completed a sixty- to a ninety-day residential PTSD
treatment program between 2000 and 2007 at a large medical
center in the VHA. This site houses two PTSD Residential
Rehabilitation Programs (PRRP), consisting of a 45-bed program
for men and 10-bed program for women. The men’s program has
existed since 1978 and the women’s program began nearly twenty
years ago. These programs provide treatment to veterans from all
eras of military service with combat-related PTSD and related
problems. The number of PRRPs in the VHA has varied since
their inception in the 1970s and treatment procedures might differ
from one program to another. Of the 22 PRRP sites in the VHA
at this time, these two have a national catchment area and
represent large programs for the men and women whom they
serve. Veterans reside in a therapeutic milieu setting during each
of these programs in which they participate in a range of
psychological interventions throughout the day and evening hours
(e.g., discussing traumas via exposure sessions, anger management,
stress reduction, communication skills, psychoeducation, interper-
sonal process groups, parenting skills, recreation therapy).
Treatment is exclusively provided in a group format in these
programs and largely adheres to a cognitive behavioral frame-
work.
Admissions to these two programs were based on clinician
referrals for veterans with severe PTSD symptomatology who had
not improved sufficiently through less intensive treatment options.
Exclusion criteria included active psychotic symptoms, alcohol/
drug misuse within the previous 14 days, and the presence of
medical conditions that would significantly interfere with/or
prevent their engagement in any treatment activities/procedures.
Responses to PTSD Residential Treatment
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All of these participants had a primary diagnosis of PTSD from the
program staff. Although we could not closely monitor diagnostic
procedures across these assessments, PTSD diagnoses were based
on clinical interviews and objective instruments that are commonly
implemented in the VHA (e.g., Posttraumatic Clinical Checklist
[PCL]). Diagnostic information for other psychiatric disorders was
not available for most of the patients in the sample. In cases where
veterans had more than one admission to these programs, we only
incorporated information from their first admission in the
statistical analyses.
The average length of stay in the two programs at this site was
66 days and the average age in the sample was 51.53 years (SD
=8.03). The sample was predominantly comprised of men (89.1%)
and persons who self-identified as Caucasian (59.5%) in their
ethnic background. Other ethnicities included African American
(16.6%), Latino/a (14.7%), Asian American (2.2%), Native
American (1.9%), and other minority groups (5.1%). Nearly half
of the veterans were divorced (35.8%) or separated (8.0%), 32.1%
were married or living with a domestic partner, 18.4% had never
married, and 5.7% had been widowed. On average, these
participants had 11.61 years (SD=1.31) of formal education.
The median annual income ranged from $20,000 to $30,000. The
sample largely included Vietnam Veterans; 4.2% had served in
Iraq and/or Afghanistan.
Procedures
All measures that form the basis of this study were completed
primarily for clinical decision-making and quality management of
the two residential programs. However, prior to the collection of
data, a consent process was approved by Stanford University’s
Institutional Review Board (IRB) for Human Subjects in Medical
Research (Protocol #80713) and the VA Research and Develop-
ment (R & D) Committee that allowed these residential patients to
provide written permission on the pre-treatment questionnaire for
their clinical assessments to be used for research purposes. In 2007,
this protocol was closed and a de-identified data set was approved
by the Stanford IRB and the R & D Committee for the types of
research analyses that were conducted in this study (Protocol
#12236).
Assessment of PTSD symptom severity was completed via the
PCL at pre-treatment, post-treatment, and follow-up (four months
after discharge). In addition, veterans completed several other self-
report instruments at pre-treatment that might also affect their
responses to treatment. Given the aims of the present study, we
excluded 221 veterans who were admitted to the program during
the same period but only provided information on PTSD at one
time point and/or did not complete these other study measures at
pre-treatment. When compared to the 805 veterans who are the
focus of this study, preliminary analyses revealed that these
individuals with an incomplete response reported less combat
exposure, p= .004. However, these groups did not differ in their
PTSD symptom severity at pre-treatment or on any of the
remaining variables that form the basis for this study.
Measures
The Combat Experiences Scale (CES) [34] was used to assess
exposure to life-threatening activities/circumstances that may
occur in a war-zone (e.g., taking incoming fire, firing weapon,
danger of injury/death). The CES is a well-established measure
that includes seven items scored on a five-point scale, with anchor
points from 1 (Never) to 5 (51+ times).
The Medical Outcomes Study Short Form (SF-12) [35] was
incorporated to assess patients’ physical (e.g., mobility, lack of
pain, activity restriction) and mental (e.g., feeling calm/peaceful,
depressed mood) health. Higher scores indicate better health status
in each domain. Other studies have also found that the physical
health component of the SF-12 is associated with medical issues
[36] and the mental health component is predictive of psychiatric
comorbidity (e.g., depression) [37].
Pre-treatment substance abuse was gauged with an 18-item
instrument assessing standard problems that can result from heavy
alcohol/drug misuse over a number of domains (e.g., legal,
financial, residential, interpersonal) [38]. These items were rated
on a five-point scale such that higher scores indicated more
substance-related problems (1 = Never, 5 = Often).
PTSD symptomatology related to military experiences was
assessed at the three time points with the Posttraumatic Stress
Disorder Checklist – Military version (PCL-M) [39,40]. The PCL-
M is another widely used self-report instrument assessing distress
associated with the 17 symptoms of PTSD in DSM-IV over the
past month. Items were rated on a five-point scale, with anchor
points of 1 (Not at all) to 5 (Extremely). A cutoff score of 50 has
been recommended for a probable PTSD diagnosis.
Plan of Analysis
We first calculated descriptive statistics and bivariate correla-
tions between the study variables. Using MPlus Version 6.1 [41],
we next performed LCGA to identify groups of veterans (i.e.,
classes) with unique trajectories of PTSD symptomatology from
pre-treatment to post-treatment to follow-up. In light of prior
research with LCGA with clinical [42] and non-clinical [43]
groups that found longitudinal changes in PTSD symptomatology,
we anticipated to also find multiple trajectories of treatment
response in this sample. As such, we examined a 1-, 2-, 3-, and 4-
class solution, and a variety of fit indices were considered when
determining the best-fitting model.
In particular, we considered the Bayesian Information Criterion
(BIC) and Akaike Information Criterion (AIC), with lower values
indicating better fit, as well as the Vuong-Lo-Mendell-Rubin
Likelihood Ratio Test (VLMR-LRT), which tests the relative
merits of a given model against a model with one fewer classes
(e.g., a 3-class vs. a 2-class model). The VLMR-LRT produces a p
value, which represents the probability that a more complex model
fits the data just as well as a simpler model with one fewer classes.
Thus, a VLMR-LRT with a p,.05 indicates that adding another
class to the model significantly improves fit. Simulation research
has found that the VLMR-LRT is a particularly promising index
in determining the appropriate number of classes [44]. We also
report values for entropy, which is a measure of classification
uncertainty. Although there is no clear cutoff for acceptable levels
of entropy [45], values closer to 1 indicate clear delineation of
classes and values closer to 0 indicate greater classification
uncertainty [46]. Parameters in the LCGA were estimated using
a maximum likelihood robust (MLR) procedure, which is robust
even in the presence of non-normal data. Shapiro-Wilk tests
revealed that PCL scores at all three time points significantly
deviated from normal (all p’s,.001).
Several covariates were included in the model based on previous
research: age, sex (0 = women, 1= men), ethnicity (0 = ethnic
minority, 1 = Caucasian), combat exposure, physical health,
mental health, and substance abuse. Multinomial logistic regres-
sion was used to determine which covariates significantly predicted
class membership. Missing data was handled using multiple
imputation, which has the advantage of providing unbiased
estimates while making use of all available data. Five imputations
were performed, which is ‘‘sufficient to obtain excellent results’’ (p.
548) [47]. Only 2 participants had a missing PCL score at baseline;
143 had a missing PCL score at post-treatment; and 326 had a
Responses to PTSD Residential Treatment
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missing PCL score at follow-up. In order to be included in the
present study, a participant could not omit more than 3 items on
the PCL and was required to have valid PCL scores at a minimum
of two assessments.
Results
Bivariate Analyses
Descriptive statistics and bivariate correlations are outlined in
Table 1. All of the study variables were linked with PTSD
symptom severity at least at one of the assessment points. Combat
exposure, baseline health status, and problems with substance
abuse were correlated with veterans’ symptomatology at each of
the three assessments in the anticipated directions.
Latent Class Growth Analysis Findings
After testing a 1-, 2-, 3-, and 4-class model in the LCGA, a 3-
class model was clearly found to provide the best fit to the data (see
Table 2). A graphical depiction of this model is provided in
Figure 1. In this figure, solid lines represent estimated means
based on the LCGA probabilistic model. These estimated
trajectories are straight lines since we had three time points and
could only test linear models (i.e., a quadratic model would require
4 or more longitudinal observations). Dotted lines in this figure
represent trajectories based on actual sample means and therefore
deviate from the probabilistic LCGA model and do not conform to
a perfect linear pattern.
As shown in Figure 1, 48.8% exhibited a trajectory character-
ized by moderate levels of PTSD symptomatology that signifi-
cantly declined from pre-treatment to follow-up (Intercept
= 61.322, p,.001; Slope =22.274, p,.001). Veterans with this
trajectory were considered to have ‘‘Improving Moderate PTSD.’’
A smaller subset of individuals (41.0%), labeled the ‘‘Stable High
PTSD’’ group, showed more severe baseline levels of PTSD
symptomatology that remained fairly stable (Intercept = 72.043,
p,.001; Slope =20.672, p= .158). A third group (10.2%)
displayed relatively low initial levels of PTSD symptoms that also
remained relatively stable over time (Intercept = 44.322, p,.001;
Slope =20.859, p= .523); individuals with this trajectory made
up a ‘‘Stable Low PTSD’’ group. To ensure that these results were
not biased due to our method of handling missing data, these
analyses were repeated using the method of listwise deletion.
These analyses also supported a three-class model with highly
similar frequencies of participants within each class (i.e., 48.7%,
43.0%, and 8.4% in the moderate, high, and low PTSD groups,
respectively).
Given the observed discrepancy between some of the estimated
means from the LCGA model and the actual means in the sample
(particularly at post-treatment), mean PCL scores were compared
within each class at all three assessments as well as effect sizes for
the three groups for changes in PTSD symptomatology from pre-
to post-treatment, pre-treatment to follow-up, and post-treatment
to follow-up. As shown in Table 3, each group reported significant
reductions in PTSD symptomatology from pre- to post-treatment
(ds =2.42 to2.78). However, all three groups reported significant
increases in symptomatology from post-treatment to follow-up (ds
= .26 to .59), indicating some degree of relapse in the months after
treatment. When compared to their PCL scores at baseline, only
those in the Improving Moderate PTSD group showed reductions
in symptomatology that remained significantly different from zero
at follow-up (d =2.50).
Examination of the covariates in the LCGA model revealed that
the Stable High PTSD group was primarily characterized by
greater combat exposure and poorer status in both physical and
mental health compared to the Improving Moderate PTSD group
(see Table 4). In contrast, those in the Stable Low PTSD group
were older, experienced fewer combat stressors, reported better
physical and mental health status, and had fewer problems with
substance abuse compared to the Improving Moderate PTSD
group. When the Stable Low PTSD and Stable High PTSD
groups were compared directly, the Stable High PTSD group was
found to have greater combat exposure, poorer mental and
physical health, and more problems with alcohol.
Discussion
This study revealed three distinct trajectories of changes in
PTSD symptomatology. As anticipated, nearly half of the patients
(48.8%) demonstrated significant reductions in PTSD at post-
treatment that were maintained at follow-up. The next most
common trajectory entailed a Stable High PTSD group (41%) and
another smaller minority (10.2%) of patients consistently hovered
below the cutoff for symptom severity on the PCL. Although
veterans in these groups had significant reductions in PTSD
symptom severity at discharge, neither group generated significant
therapeutic benefits at follow-up. Of note, we also did not find
evidence for a class of patients who worsened during and/or after
their admission. However, in keeping with earlier outcomes with
smaller samples of residential patients [17–21], a shallow v-shaped
pattern of changes in PTSD was observed across these three
trajectories. Namely, all veterans reported a significant ameliora-
tion of PTSD at discharge but then went on to experience a
resurgence of symptomatology in the four months after the
Table 1. Descriptive Statistics and Bivariate Correlations Between Study Variables.
M SD PTSD at Pre-treatment PTSD at Post-treatment PTSD at Follow-up
Age 51.632 8.066 2.085* .024 .055
Sex 0.891 0.311 .065 .153*** .123***
Ethnicity 0.595 0.491 2.072* 2.050 2.012
Combat Exposure 21.924 12.272 .158*** .224*** .127***
Physical Health Status 38.809 10.138 2.169*** 2.136*** 2.126***
Mental Health Status 30.760 9.083 2.336*** 2.224*** 2.197***
Substance Abuse Problems 32.950 17.690 .218*** .134*** .119***
Note: ***p,.001, **p,.01, *p,.05; M = mean, SD = standard deviation, PTSD = Posttraumatic Stress Disorder. Sex was coded in such a manner that 0 = Women, 1 =
Men. Ethnicity was coded such that 0 = Non-Caucasian, 1 = Caucasian persons.
doi:10.1371/journal.pone.0101741.t001
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program. When considering the Stable High and Low PTSD
trajectories in particular, these relapses unfortunately negated
gains from treatment. Although we lacked information on factors
that contributed to these relapses, previous research suggests that
limited psychosocial resources and possible environmental defi-
ciencies outside of the program serve as important maintenance
factors for PTSD among many veterans with this condition [23].
Other results indicated that veterans who responded favorably
to treatment could be distinguished by several pre-treatment
factors. When considering PTSD symptom severity, veterans in
the Moderate Improving PTSD group scored in an intermediate
range relative to those who returned to their baseline levels of
symptomatology. In addition, patients with an improving trajec-
tory had superior physical and mental health status than those in
the Stable High PTSD group. In contrast, when compared to the
Stable Low PTSD group, veterans with an improving trajectory
indicated poorer health status before treatment began. Results
from this second comparison also revealed that these responders
were generally younger and had more problems with substance
abuse than the Stable Low PTSD group, each of which conflicted
somewhat with our hypotheses. This pattern rather suggests that
PTSD treatment could have the greatest probability of success in
an intermediate range of symptom severity and co-occurring
medical/psychiatric problems. From a clinical standpoint, the
ideal patient might therefore need to reach a certain level of
distress and/or impairment to garner the necessary motivation to
engage in therapeutic activities/procedures. However, in cases of
severe PTSD in which patients might also find themselves
struggling with serious comorbid medical/psychiatric issues,
clinicians could encounter greater challenges in addressing
trauma-related concerns in an effective manner.
This same pattern for treatment outcomes was also observed for
exposure to combat. Namely, although bivariate correlations
supported a well-established association between combat exposure
and severity of posttraumatic symptomatology [48], patients were
in fact the most likely to benefit from treatment if they
encountered a certain degree of potentially traumatic scenarios
during their war-zone service. However, once these patients had
surpassed a possible threshold of exposure, results indicated that
the possibility of responding favorably to treatment was lessened.
Other research has documented that under conditions of severe
exposure to the types of life-threatening stressors assessed in this
study, veterans will be more likely to encounter a diversity of
additional traumas that may create unique challenges for treating
combat-related PTSD [24,25]. Hence, when focusing on the
Stable High PTSD group in particular, many of these patients
might have been struggling to resolve other salient traumas (e.g.,
killing, atrocities) that were not captured by the traditional combat
exposure measure used in this study. Several researchers have
piloted interventions that may address shame/guilt and other
dimensions of moral injury in evidence-based treatments for
combat-related PTSD [49,50].
It was notable that veterans’ ages and problems with alcohol/
drugs did not significantly differ for the Moderate Improving
PTSD and Stable High PTSD groups. These results could be
attributable to a restricted range in these variables in that the
program was just beginning to serve Iraq/Afghanistan veterans
when the data was collected and substance-related problems are
quite common in these residential contexts. However, these results
Figure 1. Graphical depiction of the 3-class solution for PCL-M scores from pre-treatment to a four-month follow-up assessment.
Solid lines represent trajectories based on estimated means. Dotted lines represent trajectories based on actual means in the sample.
doi:10.1371/journal.pone.0101741.g001
Table 2. Goodness of Fit Indices for Latent Class Growth Analysis Examining Posttraumatic Stress Symptoms from Pretreatment to
Follow-up (N= 805).
AIC BIC Entropy VLMR-LRT p value
1-Class 19124.116 19147.570 — —
2-Class 18533.766 18604.128 .732 ,.001
3-Class 18350.847 18468.118 .735 ,.001
4-Class 18339.694 18503.874 .785 .114
Note: AIC = Akaike Information Criterion, BIC = Bayesian Information Criterion, VLMR-LRT = Vuong-Lo-Mendell-Rubin Likelihood Ratio Test. Missing data was handled
using multiple imputation with five imputed data sets. Mean values across these data sets are presented for AIC, BIC, and Entropy, and the median p value is presented
for the VLMR-LRT.
doi:10.1371/journal.pone.0101741.t002
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also raise questions about whether or not chronicity of PTSD and
problems with substance misuse represent barriers for treatment
with this population to the same degree as medical issues and
psychiatric comorbidities. Recent results from two samples of
VHA PTSD residential patients unexpectedly found that those
with comorbid SUDs had superior PTSD outcomes compared to
cases of PTSD only [51]. Findings such as these highlight the
potentially synergistic effects of PTSD and SUDs in the
therapeutic context. For example, as SUD symptoms will be
confronted via a period of forced sobriety in residential treatment,
veterans might be positioned to emotionally process their traumas
(and vice versa). VHA clinicians are frequently well-versed in
integrative methods with demonstrated efficacy for addressing
PTSD and SUDs [52]. The present results additionally support
the need for integrated health care and close collaboration
between mental health clinicians and medical providers in the care
of veterans with combat-related PTSD.
Limitations
Any conclusions drawn from this study should be tempered
against several limitations. We already noted the predominance of
veterans from the Vietnam era. With the expanding role of women
in the military over recent decades, there was similarly a high
predominance of men in this group. As such, these results may not
generalize as well to women and the new generation of Iraq/
Afghanistan veterans, and future studies on PTSD treatment
responses will do well to over-sample these subgroups. With our
exclusive focus on veterans presenting for residential treatment at a
single site, these results may also not apply to non-clinical
populations of veterans, those with sub-threshold PTSD, or
veterans who pursue treatment at other PRRPs in the VHA. It
was notable that patients in the Stable Low PTSD group generally
did not exceed the threshold on the PCL [31]. However, this
trajectory occurred with the least frequency and the LCGA results
might not generalize to outcomes with less severe cases that
clinicians may treat in other settings. For instance, considering the
greater representation of older veterans with lower combat
exposure in the Stable Low PTSD group, it is possible that some
of these persons might not have identified as easily with other
veterans in their cohorts and/or many of them could have sought
treatment for different reasons. Some of these patients might have
accordingly benefitted from a more individualized approach or
greater homogeneity in their cohort. These are constant tensions
with treating combat-related PTSD in residential settings that we
did not have information to address in our study [15].
Given the multiple interventions that veterans received in their
treatment, we also could not examine the relations between
specific components of the residential programs with the PTSD
trajectories derived in the LCGA. Research has demonstrated that
the VHA’s systematic implementation of evidence-based, trauma-
focused psychotherapies for PTSD (e.g., cognitive processing
therapy, prolonged exposure) has increased the efficacy of
treatments in both residential [14] and outpatient [16] settings.
However, because of changes in program staff and introduction of
these interventions over the study period, the treatment programs
would not have been exactly the same for each of the patients in
this sample. As such, we lacked information for testing the
incremental benefit of specific components of the overall
treatment. Although this clinical sample provided a unique
opportunity to address our study aims, future research should
examine the helpfulness of different treatment components in a
more systematic manner. The assessment of combat exposure and
PTSD was also restricted to life-threatening stressors and DSM-
IV’s emphasis on fear-based symptomatology. In keeping with
recent changes in DSM 5 criteria for PTSD, there is increasing
consensus that combat-related PTSD can emerge from a much
more diverse set of war-zone experiences that frequently entail a
far wider realm of emotions than many clinicians and researchers
have historically appreciated [25]. As such, we possibly missed
important factors for distinguishing patients who displayed
improvement in PTSD vs. the remainder of the sample who did
not achieve lasting reductions in their trauma-related symptom-
atology.
Conclusion
Notwithstanding these limitations, this study addresses a
pressing public health concern and notable strengths include the
relatively large sample size, focus on a PTSD residential sample,
and sophisticated statistical methodology. Findings generally align
with other research that documented a lack of positive effects for
PTSD residential programs in alleviating the symptomatology of
U.S. veterans [17–21]. However, the present study also identified
several patient characteristics that were prospectively associated
with varying trajectories in PTSD outcomes that clinicians might
consider in their work. When compared to non-responders (follow-
up ds =2.15 and 2.13), patients who had responded favorably to
treatment (follow-up d=2.50) scored in an intermediate range in
symptom severity, physical/mental health status, and combat
exposure. This pattern supports the clinical wisdom that the ideal
patient for PTSD treatment will neither be too healthy or
debilitated by psychiatric and medical problems. In the former
situation, clinicians may explore other less expensive treatment
options for addressing veterans’ concerns. However, when
considering the 41% of this sample who maintained high levels
of PTSD despite the completion of an intensive residential
program, this study reinforces the need for more effective
strategies for helping this extreme subpopulation of veterans
seeking services for PTSD in the VHA. The present results suggest
that clinicians should be prepared to assume a synergistic and
holistic approach in these cases, which may combine evidence-
based treatments for alleviating PTSD symptomatology with other
strategies for promoting veterans’ health in physical, social, and
potentially spiritual domains. With a new generation of veterans
now relying on services in an already burdened VHA system, it
will be critical for providers from multiple disciplines to collaborate
together in optimizing the treatment of combat-related PTSD in
the years to come.
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